Admissions:
None
Delistings:
None
Potential** Initial Public Offerings:
Upcoming Market Movers:
6 February: Creightons (CRL.L) has announced an intention to move to AIM from the Main Market. It is expected that the last day of dealings in the Ordinary Shares on the Main Market will be 28 March 2025. Dealing in the Ordinary Shares is expected to commence on AIM, at 8.00 a.m. on 31 March.
Capital Limited 60.4p £118.5m (CAPD.L)
The mining services Company provided an update on anticipated profitability for FY 2024, the outlook for 2025 and news of management changes. The Board has taken the decision to book non-cash provisions in 2024 primarily relating to historical VAT receivables and various laboratory assets in Mali. The Company now expects net profit after tax for 2024 to be in the range of $18–$20m. The Company will announce FY 2024 results on the 27th March.
FY 2025 revenue is expected to be in the range of $300-$320m. The Company's CEO, Peter Stokes, has tendered his resignation which has been accepted by the Board.
Cora Gold Ltd 4.15p £18.8m (CORA.L)
The West African focused gold Company noted that on 7 March 2025 the Government of the Republic of Mali announced a partial lifting of the suspension relating to the allocation of mining titles. This partial lifting of the moratorium, which had originally been put in place by the Government on 28 November 2022, will come into effect on 15 March 2025. Cora sees the partial lifting of the moratorium as a significant and positive turning point for the mining sector in the country and for its flagship Sanankoro Gold Project in south Mali. Cora's primary focus is advancing permitting at Sanankoro to develop an open pit oxide mine as expeditiously as possible.
Empire Metals Limited 11.55p £74.2m (EEE.L)
The resource exploration and development Company announced the results from its recent titanium dioxide (TiO2) product development testwork programme, carried out on mineral concentrates produced from the in-situ mineralised weathered cap that extends across the Pitfield Project, located in Western Australia. Preliminary testwork has delivered a high-purity TiO2 product, which assayed at 91.6% TiO2. The TiO2 product under development was entirely free of any deleterious impurities and is suitable for high-quality titanium sponge metal or high-grade titanium dioxide pigment production.
HydrogenOne Capital Growth 20.85p £26.9m (HGEN.L)
The London-listed fund investing in clean hydrogen, reports that portfolio company Elcogen AS, a European manufacturer of solid oxide technology has announced the launch of the Horizon Europe SYRIUS project, with Acciai Speciali Terni Spa, a leader in Europe's stainless-steel sector. The SYRIUS project will seek to decarbonise the steel production process through hydrogen production and circular energy use. The SYRIUS project, which is backed by a EUR10m grant from Horizon Europe, will integrate a 4.2 MW Solid Oxide Electrolyser into an Electric Arc Furnace plant, which will enable sustainable steel production. As at 31 December 2024, HydrogenOne's investment in Elcogen represented 18% (£21m) of the Company's NAV.
Mindflair 1p £5.3m (MFAI.L)
The Company investing in next-generation technology focused on AI announced that it has agreed to sell its entire directly held unquoted minority position in Visibility Blockchain Limited (Getvisibility) to Forcepoint, a global leader in data and cloud security. Getvisibility is a cybersecurity company focusing on data visibility and control and uses state-of-the-art artificial intelligence to classify and secure unstructured information. The Disposal is expected to generate a gross cash inflow to the Company of approximately EUR2.1m (£1.8m). In addition, Mindflair has an indirect interest in Getvisibility through its investment in the first Sure Valley Ventures fund (SVV1) and through its shareholding in Sure Ventures plc which in turn has a 25.9% interest in SVV1.
NWF Group 174.5p £86.3 (NWF.L)
The specialist distributor has acquired all the issued share capital of Northern Energy Oil Ltd for £8.3m. It distributes 42m litres of fuel from five sites in North Yorkshire, Northumbria and Lincolnshire, with a largely domestic customer base which is an area where NWF is underrepresented. In the 12 months to August 2024, Northern Energy generated revenue of £35.1m, EBITDA of £0.6m, and PBT of £0.1m with net assets of £2.7m. These results included non-recurring costs of approximately £0.6m. Northern Energy is expected to be immediately earnings accretive and to benefit from margin expansion once fully integrated. This is in line with the strategy to grow its fuels distribution business through consolidation and it is the first acquisition since 2023.
PCI-PAL 56.5p £40.9m (PCIP.L)
The global cloud provider of secure payment solutions for business communications today announces its strategic partnership and embedded live integration with RingCentral, a leading global provider of AI-powered cloud communications. This collaboration, the contract for which was previously referred to in the Company's trading update of 28 August 2024, is now live across North America and Europe regions and enables RingCentral customers to securely handle payments across any channel and any environment within the RingCentral platform.
Polarean Imaging 1.275p £15.4m (POLX.L)
The commercial-stage medical imaging technology operator in advanced Magnetic Resonance Imaging (MRI) of lung function announced the expansion of a new imaging service model to enable the use of Xenon MRI in pharma-sponsored research, alongside its partner VIDA Diagnostics. This coincides with its selection by a global pharmaceutical partner to utilise the new Xenon MRI clinical trial support services platform as part of a sub-study within a worldwide multi centre study trial testing an investigational lung therapy. This new revenue-generating service model builds upon initial experience last year with an industry partner who selected Xenon MRI ventilation defect percentage as the primary endpoint in testing different inhaled drug-delivery devices at a single site.
Versarien 0.0325p £1.5m (VRS.L)
The engineering materials Company announced further to the manufacturing licence agreement, know-how licence and technical assistance agreement entered into with Montana Química LTDA, as announced on 14 March 2024, that it has now signed a two-year supply agreement to provide certain of the Company's proprietary graphene and related material dispersions and formulations to Montana. The revenue that Versarien will receive under the Supply Agreement is in addition to the Company's existing royalty agreement with Montana that provides an amount equal to 5% of the total sales revenue earned from products manufactured using Versarien's intellectual property and know-how, subject to minimum royalty payments of £25,000 per annum.
Zinnwald Lithium 6.1p £28.9m (ZNWD.L)
The European focused lithium Company developing the integrated Zinnwald Lithium Project in Germany announced its final audited results for the year ended 31 December 2024. Across the period, the Company announced two updates to the Mineral Resource Estimate and confirmed the Project's position as the second-largest hard rock lithium project in the EU and increasing ore tons in the Measured category. The Company explored the potential to expand the Project in phases, starting with Phase 1 producing 16,000-18,000 tonnes per annum (tpa) of battery-grade Lithium Hydroxide, a 50% increase from the 2022 estimate of 12,000 tpa.
Status of this Note and Disclaimer
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
